Introduction

The current standard of care for the frontline treatment of classical Hodgkin lymphoma includes Doxorubicin, bleomycin, vinblastine, and decarbazine. Despite the high cure rates achieved with this approach, many patients will relapse and require intensive second-line therapies. Learn more about the effects of targeting the CD40, CD40 ligand axis in Waldenström macroglobulinemia. Review the findings from a study aimed at improving the bone marrow homing of car cytokine-induced killer cells in AML.